タンパク質摂取がグルカゴン、インスリン、グルコース動態に及ぼす影響:糖尿病への示唆
Sarah Nagy1, Lauren V Turner1, Michael C Riddell1
1School of Kinesiology and Health Science, York University, Toronto, ON, Canada.
Abstract:
Carbohydrates are the main macronutrient of interest for dosing insulin and managing glycemia in type 1 diabetes (T1D) due to their direct impact on blood glucose levels, however, the influence of protein on glycemia and pancreatic islet hormone secretions in people living with either T1D or type 2 diabetes (T2D) should not be overlooked. Protein ingestion plays a key role in the secretion of both insulin and glucagon, making it a key regulator of blood glucose levels in health and diabetes. The glycemic response to protein is affected by many factors including the protein's form, source, digestion rate, whether it is consumed on its own or in a mixed meal, as well as its timing in relation to other meals and/or physical activity. Additionally, the hormonal and glycemic response to protein differs markedly between non diabetic individuals, T1D, and T2D. The unique ability of protein to modify post-prandial glycemia makes it a potential tool that individuals with diabetes or prediabetes can utilize to help manage their own glycemia. This review will discuss the ways in which protein intake and supplementation with certain protein types may be able to improve overall glycemia and time in range for individuals living with diabetes or prediabetes.
さらに関連する動画
08:01Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
08:03Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
関連する概念動画
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Regulation of Water Intake
Regulation of Food Intake
